The Technical Analyst
Select Language :
Cerevel Therapeutics [CERE]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Cerevel Therapeutics Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Cerevel Therapeutics is listed at the  Exchange

-0.24% $42.28

America/New_York / 28 mar 2024 @ 09:31


Cerevel Therapeutics: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 7 677.03 mill
EPS: -2.67
P/E: -15.84
Earnings Date: Apr 30, 2024
SharesOutstanding: 181.58 mill
Avg Daily Volume: 1.586 mill
RATING 2024-03-27
B+
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Sell
DE: Strong Buy
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -15.84 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-2.69x
Company: PE -15.84 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$3.15
(-92.55%) $-39.13
Date: 2024-03-28
Expected Trading Range (DAY)

$ 41.94 - 42.76

( +/- 0.97%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-04 Coles N Anthony Sell 50 000 Stock Option (Right to Buy)
2024-03-04 Coles N Anthony Buy 50 000 Common Stock
2024-03-04 Coles N Anthony Sell 50 000 Common Stock
2024-02-29 Coles N Anthony Sell 50 000 Stock Option (Right to Buy)
2024-02-29 Coles N Anthony Buy 50 000 Common Stock
INSIDER POWER
84.34
Last 99 transactions
Buy: 19 154 412 | Sell: 1 502 762

Forecast: 11:10 - $42.25

Live Trading Signals (every 1 min)

Forecast 1: 09:40 - $42.37
Forecast 2: 10:30 - $42.25
Forecast 3: 11:10 - $42.25
SCORE
-10.00
Sell
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $42.28 (-0.24% )
Volume 0.0025 mill
Avg. Vol. 1.586 mill
% of Avg. Vol 0.157 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Cerevel Therapeutics Holdings, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for Cerevel Therapeutics Holdings, Inc.

RSI

Intraday RSI14 chart for Cerevel Therapeutics Holdings, Inc.

Last 10 Buy & Sell Signals For CERE

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35buy$42.05N/AActive
Profile picture for
            Cerevel Therapeutics Holdings, Inc.

CERE

Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-concept trial in patients with drug-resistant focal onset seizures in epilepsy or focal epilepsy, as well as in phase 1 trial to treat acute anxiety. The company's products also comprise Tavapadon, a selective dopamine D1/D5 partial agonist that is in phase 3 clinical trial for the treatment of early- and late-stage Parkinson's disease; CVL-871, a selective dopamine D1/D5 partial agonist, which is in Phase 2a clinical trial to treat dementia-related apathy; CVL-936, a selective dopamine D3-preferring antagonist, which is in Phase I clinical trial for the treatment of substance use disorder; CVL-354, a selective kappa-opioid receptor antagonist to treat major depressive disorder and substance use disorder; and CVL-047, selective PDE4 inhibitor for the treatment of major depressive disorder and substance use disorder. It is also involved in the development of an M4 agonist program for the treatment of psychosis and related indications; and an LRRK2 inhibitor program to address disease progression in Parkinson's. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Last 10 Buy Signals

Date Signal @
ICLRMar 27 - 16:00$329.50
IBACUMar 27 - 16:0010.00
^BVSPMar 28 - 09:10PTS127 513
FTSEMIB.MIMar 28 - 09:1034 763
TOMOUSDMar 28 - 09:21$1.015
XFUNDUSDMar 28 - 09:19653.72
KUJIUSDMar 28 - 09:182.82
FIDAUSDMar 28 - 09:18$0.528
PLUUSDMar 28 - 09:175.66
FTMUSDMar 28 - 09:16$1.017

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.